Literature DB >> 15040260

Pathogenic Escherichia coli.

James B Kaper1, James P Nataro, Harry L Mobley.   

Abstract

Few microorganisms are as versatile as Escherichia coli. An important member of the normal intestinal microflora of humans and other mammals, E. coli has also been widely exploited as a cloning host in recombinant DNA technology. But E. coli is more than just a laboratory workhorse or harmless intestinal inhabitant; it can also be a highly versatile, and frequently deadly, pathogen. Several different E. coli strains cause diverse intestinal and extraintestinal diseases by means of virulence factors that affect a wide range of cellular processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15040260     DOI: 10.1038/nrmicro818

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  1467 in total

1.  Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.

Authors:  Wanyin Deng; Hong B Yu; Carmen L de Hoog; Nikolay Stoynov; Yuling Li; Leonard J Foster; B Brett Finlay
Journal:  Mol Cell Proteomics       Date:  2012-06-01       Impact factor: 5.911

2.  Mosaic structure of the small cryptic plasmid pKST23 from Escherichia coli.

Authors:  L Fecskeová; M Kovařík; P Javorský; P Pristaš
Journal:  Folia Microbiol (Praha)       Date:  2012-06-02       Impact factor: 2.099

3.  Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.

Authors:  Sébastien Crépin; Sébastien Houle; Marie-Ève Charbonneau; Michaël Mourez; Josée Harel; Charles M Dozois
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

4.  Chemical sensing in mammalian host-bacterial commensal associations.

Authors:  David T Hughes; Darya A Terekhova; Linda Liou; Carolyn J Hovde; Jason W Sahl; Arati V Patankar; Juan E Gonzalez; Thomas S Edrington; David A Rasko; Vanessa Sperandio
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

5.  Verotoxin 2 enhances adherence of enterohemorrhagic Escherichia coli O157:H7 to intestinal epithelial cells and expression of {beta}1-integrin by IPEC-J2 cells.

Authors:  Bianfang Liu; Xianhua Yin; Yanni Feng; James R Chambers; Aiguang Guo; Joshua Gong; Jing Zhu; Carlton L Gyles
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

6.  Control of acid resistance pathways of enterohemorrhagic Escherichia coli strain EDL933 by PsrB, a prophage-encoded AraC-like regulator.

Authors:  Ji Yang; Thomas W Russell; Dianna M Hocking; Jennifer K Bender; Yogitha N Srikhanta; Marija Tauschek; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

7.  Occurrence of Antimicrobial-Resistant Escherichia coli and Salmonella enterica in the Beef Cattle Production and Processing Continuum.

Authors:  John W Schmidt; Getahun E Agga; Joseph M Bosilevac; Dayna M Brichta-Harhay; Steven D Shackelford; Rong Wang; Tommy L Wheeler; Terrance M Arthur
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

8.  Characterization of a verocytotoxin-producing enteroaggregative Escherichia coli serogroup O111:H21 strain associated with a household outbreak in Northern Ireland.

Authors:  Tim Dallman; Geoffrey P Smith; Brendan O'Brien; Marie A Chattaway; David Finlay; Kathie A Grant; Claire Jenkins
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

9.  Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome.

Authors:  Marjorie De la Fuente; Luigi Franchi; Daniela Araya; David Díaz-Jiménez; Mauricio Olivares; Manuel Álvarez-Lobos; Douglas Golenbock; María-Julieta González; Francisco López-Kostner; Rodrigo Quera; Gabriel Núñez; Roberto Vidal; Marcela A Hermoso
Journal:  Int J Med Microbiol       Date:  2014-02-06       Impact factor: 3.473

10.  Characterization and studies of the cellular interaction of native colonization factor CS6 purified from a clinical isolate of enterotoxigenic Escherichia coli.

Authors:  Abhisek Ghosal; Rudra Bhowmick; Rajat Banerjee; Sandipan Ganguly; S Yamasaki; T Ramamurthy; T Hamabata; Nabendu Sekhar Chatterjee
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.